Table 2. Means, SDs and effect sizes (Cohen’s d) for measures of depression, anxiety, psychological flexibility and quality of life.
Mean (SD) | Effect size, d (95% CI) | ||||||
---|---|---|---|---|---|---|---|
Outcome measure | Pre-treatment | Post-treatment | Follow-up | Between-group, pre to post | Between-group, pre to follow-up | Within-group, pre to post | Within-group, pre to follow-up |
BDI-II | |||||||
Blended treatment | 28.96 (8.07) | 15.17 (11.51) | 14.61 (12.86) | -0.13 (-2.37, 2.09) | -0.10 (-2.53, 2.33) | 1.40 (-0.61, 3.41) | 1.35 (-0.82, 3.52) |
Full BA treatment | 27.32 (7.89) | 13.68 (10.68) | 13.43 (11.27) | 1.47 (-0.41, 3.35) | 1.44 (-0.50, 3.39) | ||
PHQ-9 | |||||||
Blended treatment | 15.39 (4.73) | 7.13 (5.78) | 7.20 (6.13) | 0.01 (-1.20, 1.23) | 0.05 (-1.18, 1.27) | 1.58 (0.51, 2.65) | 1.51 (0.41, 2.62) |
Full BA treatment | 15.30 (4.49) | 7.21 (6.27) | 7.49 (6.06) | 1.50 (0.41, 2.59) | 1.48 (0.42, 2.55) | ||
BAI | |||||||
Blended treatment | 15.74 (12.11) | 8.11 (9.27) | 12.57 (12.30) | 0.36 (-1.48, 2.20) | 0.03 (-2.30, 2.37) | 0.72 (-1.46, 2.89) | 0.26 (-2.20, 2.73) |
Full BA treatment | 17.47 (9.18) | 11.34 (9.02) | 12.96 (10.87) | 0.68 (-1.14, 2.50) | 0.45 (-1.56, 2.47) | ||
AAQ-II | |||||||
Blended treatment | 30.41 (7.15) | 25.78 (7.09) | 24.30 (8.37) | -0.01 (-1.62, 1.60) | -0.07 (-1.83, 1.68) | 0.66 (-0.78, 2.10) | 0.79 (-0.78, 2.37) |
Full BA treatment | 30.64 (7.68) | 25.72 (8.82) | 23.66 (9.06) | 0.60 (-1.05, 2.26) | 0.84 (0.84, 2.52) | ||
QOLI | |||||||
Blended treatment | -0.68 (1.72) | 0.81 (1.99) | 0.82 (2.08) | 0.01 (-0.36, 0.37) | 0.03 (-0.35, 0.40) | 0.80 (0.43, 1.18) | 0.79 (0.41, 1.18) |
Full BA treatment | -0.44 (1.44) | 0.79 (1.65) | 0.78 (1.67) | 0.80 (0.49, 1.11) | 0.79 (0.48, 1.10) |
Abbreviations: BDI-II: Beck Depression Inventory-II; PHQ-9: 9-item Patient Health Questionnaire Depression Scale; BAI: Beck Anxiety Inventory; AAQ-II: Acceptance and Action Questionnaire; QOLI: Quality of Life Inventory.